(57) @ The invention provides novel imidazoquinolines, processes for their preparation
and pharmaceutical compositions containing them. The compounds have Formula I
wherein A is a C1-C4 straight or branched alkylene chain which may be saturated or unsaturated, B is a
C2-C4 straight or branched alkylene chain which may be saturated or unsaturated, R' and
R2 are the same or different and are hydrogen, alkyl, alkoxy, alkoxyalkyl, hydroxyalkyl,
hydroxy, halogen, nitro, carboxy, carboxylic ester, carbamoyl, carbamoyloxy, cyano,
acyl, acylamino or trifluoromethyl, Het is a heterocyclic group chosen from imidazolyl,
imidazolinyl, benzimidazolyl, thiazolyl, thiazolinyl, quinolyl, piperidyl, pyridyl,
benzothiazolyl and pyrimidyl, any of which heterocyclic groups may be substituted,
and x is 0 or 1, and pharmaceutically acceptable salts thereof.
The compounds are anti-ulcer/anti-secretory agents.
|
|
